2013
DOI: 10.1016/j.fertnstert.2013.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Selecting the optimal time to perform biopsy for preimplantation genetic testing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
106
0
6

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 129 publications
(112 citation statements)
references
References 32 publications
0
106
0
6
Order By: Relevance
“…This embryo was transferred and the patient delivered a healthy baby carrying a chromosomal balanced translocation (tested by amniocentesis). There may be two reasons of this embryo, one is mosaicism [6][7][8][9][10], the other is self-correction during embryo development. Several reasons have been proposed for aneuploidy selfcorrection during later developmental stages, including primary misdiagnosis, aneuploidy allocation in the trophectoderm, cell growth advantage of diploid cells in mosaic embryos, lagging of aneuploid cell division, extrusion or duplication of an aneuploid chromosome, and abundance of DNA repair gene products [16].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This embryo was transferred and the patient delivered a healthy baby carrying a chromosomal balanced translocation (tested by amniocentesis). There may be two reasons of this embryo, one is mosaicism [6][7][8][9][10], the other is self-correction during embryo development. Several reasons have been proposed for aneuploidy selfcorrection during later developmental stages, including primary misdiagnosis, aneuploidy allocation in the trophectoderm, cell growth advantage of diploid cells in mosaic embryos, lagging of aneuploid cell division, extrusion or duplication of an aneuploid chromosome, and abundance of DNA repair gene products [16].…”
Section: Discussionmentioning
confidence: 99%
“…At present, blastocyst stage is the optimal time to perform biopsies for preimplantation genetic testing [10]. Trophectoderm biopsies do less harm to development of the embryo [20], while blastocyst biopsy can obtain multiple trophectoderm cells, resulting in an increased number of DNA copies in the biopsy specimen, and therefore more accurate results compared with a single blastomere cell [21].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Both PGD and PGS require access to the DNA of the preimplanted embryos, which is provided by either polar body biopsy, blastomere biopsy of cleavagestage embryos, or trophectoderm biopsy of blastocysts. PGS is mainly performed on trophectodermal cells biopsied from blastocysts to allow a better representation of the embryo ploidity [3][4][5][6][7]. In contrast, PGD for severe monogenic disorders is usually performed on blastomeres biopsied from day 3 embryos.…”
Section: Introductionmentioning
confidence: 99%
“…The blastocyst stage is the optimal stage for performing biopsies for preimplantation genetic screening (PGS) [1]. The high efficiency of PGS at the blastocyst stage has being reported as a key factor determining the growing clinical application of this strategy worldwide [2][3][4][5][6][7].…”
Section: Introductionmentioning
confidence: 99%